Monte Rosa Therapeutics, Inc. is a biopharmaceutical company developing of novel small molecule precision medicines that use the body's natural mechanisms to selectively degrade therapeutically relevant proteins. Its programs are focused on delivering therapies to targets that have been considered undruggable or inadequately drugged in biological pathways. Monte Rosa Therapeutics was incorporated in 2019 and is headquartered in Boston, MA.
Name / Ticker | Price | Zen Rating |
---|---|---|
$24.39 | A | |
$5.69 | A | |
$68.04 | A |